These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 22291921)
1. Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. Dey AK; Burke B; Sun Y; Sirokman K; Nandi A; Hartog K; Lian Y; Geonnotti AR; Montefiori D; Franti M; Martin G; Carfi A; Kessler P; Martin L; Srivastava IK; Barnett SW PLoS One; 2012; 7(1):e30233. PubMed ID: 22291921 [TBL] [Abstract][Full Text] [Related]
2. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques. Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585 [TBL] [Abstract][Full Text] [Related]
3. Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor. Alam SM; Cronin K; Parks R; Anasti K; Ding H; Go EP; Desaire H; Eaton A; Montefiori D; Sodroski J; Kappes J; Haynes BF; Saunders KO J Virol; 2020 Oct; 94(21):. PubMed ID: 32817216 [TBL] [Abstract][Full Text] [Related]
4. Immunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization. Quinnan GV; Onabajo O; Zhang P; Yan L; Mattapallil JJ; Zhang Z; Dong M; Lu M; Montefiori D; LaBranche C; Broder CC PLoS One; 2014; 9(5):e98060. PubMed ID: 24846288 [TBL] [Abstract][Full Text] [Related]
5. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site. Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402 [TBL] [Abstract][Full Text] [Related]
6. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds. Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221 [TBL] [Abstract][Full Text] [Related]
7. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response. Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810 [TBL] [Abstract][Full Text] [Related]
8. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability. Dubrovskaya V; Tran K; Ozorowski G; Guenaga J; Wilson R; Bale S; Cottrell CA; Turner HL; Seabright G; O'Dell S; Torres JL; Yang L; Feng Y; Leaman DP; Vázquez Bernat N; Liban T; Louder M; McKee K; Bailer RT; Movsesyan A; Doria-Rose NA; Pancera M; Karlsson Hedestam GB; Zwick MB; Crispin M; Mascola JR; Ward AB; Wyatt RT Immunity; 2019 Nov; 51(5):915-929.e7. PubMed ID: 31732167 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody. Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262 [TBL] [Abstract][Full Text] [Related]
10. Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop. Ching L; Stamatatos L J Virol; 2010 Oct; 84(19):9932-46. PubMed ID: 20660181 [TBL] [Abstract][Full Text] [Related]
17. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein. Kassa A; Dey AK; Sarkar P; Labranche C; Go EP; Clark DF; Sun Y; Nandi A; Hartog K; Desaire H; Montefiori D; Carfi A; Srivastava IK; Barnett SW PLoS One; 2013; 8(10):e76139. PubMed ID: 24146829 [TBL] [Abstract][Full Text] [Related]
18. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques. Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847 [TBL] [Abstract][Full Text] [Related]
19. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D. McGuire AT; Glenn JA; Lippy A; Stamatatos L J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455 [TBL] [Abstract][Full Text] [Related]